Bevacizumab and Corneal Pathology

Medicina fluminensis
doi 10.21860/medflum2017_179759
Full Text
Abstract

Available in full text

Date
Authors
Publisher

University of Rijeka, Faculty of Medicine

Related search

Topical Bevacizumab in the Treatment of Corneal Neovascularization

Archives of Ophthalmology
2009English

Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant Survival

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) vs Bevacizumab (Avastin)

Ocular Surface
Ophthalmology
2012English

Comparison of the Effects of Subconjunctival and Topical Anti-Vegf Therapy (Bevacizumab) on Experimental Corneal Neovascularization

Arquivos Brasileiros de Oftalmologia
MedicineOphthalmology
2014English

Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2016English

Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model

Medicina
Medicine
2018English

Placido‐based Corneal Topography and Scheimpflug‐based Corneal Tomography

Acta Ophthalmologica
MedicineOphthalmology
2018English

Corneal Nerve Fiber Structure, Its Role in Corneal Function, and Its Changes in Corneal Diseases

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2017English

Corneal Higher Order Aberrations in Granular, Lattice and Macular Corneal Dystrophies

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy